VIMGF (Vimian Group AB) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 11, 2026)


VIMGF Vimian Group AB VIMGF
69 GF Score
Price $2.77
GF Value $3.19
! 2 Warning Signs
View Full Analysis

What is Vimian Group AB 5-Year Yield-on-Cost %?

Vimian Group AB VIMGF 69 5-Year Yield-on-Cost % is 0.00 as of Jul. 11, 2026. GuruFocus rates VIMGF with a GF Score™ of 69/100 and a GF Value™ of $3.19. The stock has 2 warning signs investors should review. Among 65 Medical Diagnostics & Research companies, Vimian Group AB ranks worse than 1538460% on this metric.

Vimian Group AB's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Vimian Group AB's 5-Year Yield-on-Cost % or its related term are showing as below:



VIMGF's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.45
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Vimian Group AB  (OTCPK:VIMGF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Vimian Group AB 5-Year Yield-on-Cost % Related Terms


VIMGF vs TMO, DHR, IDXX: 5-Year Yield-on-Cost % Comparison

For the Diagnostics & Research subindustry, Vimian Group AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimian Group AB 5-Year Yield-on-Cost % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Vimian Group AB's 5-Year Yield-on-Cost % falls into.


VIMGF
69GF Score
Vimian Group AB VIMGF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimian Group AB 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Vimian Group AB is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Vimian Group AB (VIMGF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 11, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Vimian Group AB and its competitors. According to the industry distribution chart, Vimian Group AB ranks #999999 out of 65 companies in the Medical Diagnostics & Research industry.
Is Vimian Group AB's 5-Year Yield-on-Cost % too high?
Vimian Group AB's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Vimian Group AB ranks #999999 out of 65 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Vimian Group AB has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Vimian Group AB's 5-Year Yield-on-Cost % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vimian Group AB ranks #999999 out of 65 companies for 5-Year Yield-on-Cost %. This places Vimian Group AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Diagnostics & Research company?
The median 5-Year Yield-on-Cost % among Medical Diagnostics & Research companies is 2.45, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Vimian Group AB and its competitors. For the Medical Diagnostics & Research industry, the median 5-Year Yield-on-Cost % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimian Group AB's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimian Group AB stock overvalued right now?
Vimian Group AB (VIMGF) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is $3.19, compared to a current price of $2.77 — trading 13.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Vimian Group AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Vimian Group AB (VIMGF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimian Group AB (VIMGF) Overvalued in 2026?

Based on GuruFocus' analysis, Vimian Group AB stock appears to be undervalued. The current stock price of $2.77 is trading 13.2% below its estimated GF Value™ of $3.19.

Key valuation signals for VIMGF:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $3.19 vs. price of $2.77 (13.2% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the VIMGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vimian Group AB Business Description

Address Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
69GF Score

Get the complete analysis for VIMGF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.77
Price
$3.19
GF Value